What is he best known for?
The fields of study he is best known for:
His primary areas of study are Stereochemistry, Oligonucleotide, Biochemistry, DNA and Binding site.
His studies deal with areas such as Antiparallel, Base pair, Thymine and Nucleotide as well as Stereochemistry.
His Biochemistry study incorporates themes from Virus and Ligand.
His biological study spans a wide range of topics, including Crystallography, Helix, Crystal structure and Molecule.
His Binding site research incorporates elements of Ubiquitin, Biophysics, Aptamer, Conserved sequence and Proteasome.
He works mostly in the field of RNA, limiting it down to topics relating to Cell biology and, in certain cases, RNA-binding protein.
His most cited work include:
- Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. (710 citations)
- Quadruplex structure of Oxytricha telomeric DNA oligonucleotides. (453 citations)
- Three-dimensional solution structure of the thrombin-binding DNA aptamer d(GGTTGGTGTGGTTGG). (314 citations)
What are the main themes of his work throughout his whole career to date?
Juli Feigon mainly investigates RNA, DNA, Stereochemistry, Crystallography and Biochemistry.
His RNA research incorporates themes from Biophysics, Molecular biology, Telomerase, Telomerase reverse transcriptase and Cell biology.
His Cell biology study deals with Telomere intersecting with Protein subunit.
Juli Feigon mostly deals with Base pair in his studies of DNA.
His Stereochemistry study combines topics from a wide range of disciplines, such as Nucleotide, Molecule, Hoogsteen base pair, Oligonucleotide and Thymine.
His Crystallography research integrates issues from Proton NMR, Nuclear magnetic resonance spectroscopy, Two-dimensional nuclear magnetic resonance spectroscopy and Hydrogen bond.
He most often published in these fields:
- RNA (34.91%)
- DNA (32.55%)
- Stereochemistry (28.77%)
What were the highlights of his more recent work (between 2011-2021)?
- Cell biology (19.81%)
- Telomerase (16.04%)
- Telomerase reverse transcriptase (13.21%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cell biology, Telomerase, Telomerase reverse transcriptase, Tetrahymena and Telomere.
Juli Feigon has researched Cell biology in several fields, including Telomerase rna and DNA.
The various areas that he examines in his DNA study include Ion, Isoguanine and Nuclear magnetic resonance spectroscopy.
His Telomerase reverse transcriptase research is multidisciplinary, incorporating elements of RNA, Non-coding RNA, Reverse transcriptase and Pseudoknot.
His research in Telomere intersects with topics in Replication protein A and Protein subunit.
Biochemistry is frequently linked to Stereochemistry in his study.
Between 2011 and 2021, his most popular works were:
- Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions. (98 citations)
- The architecture of Tetrahymena telomerase holoenzyme (79 citations)
- Structural Basis for Telomerase RNA Recognition and RNP Assembly by the Holoenzyme La Family Protein p65. (72 citations)
In his most recent research, the most cited papers focused on:
Juli Feigon focuses on Cell biology, Telomerase, Telomerase reverse transcriptase, Telomerase RNA component and RNA.
His study in Telomerase is interdisciplinary in nature, drawing from both Telomere, Protein subunit, Reverse transcriptase and Tetrahymena.
His Telomere study contributes to a more complete understanding of Biochemistry.
His Reverse transcriptase research is multidisciplinary, relying on both Base pair and DNA.
Juli Feigon works mostly in the field of Telomerase reverse transcriptase, limiting it down to topics relating to Non-coding RNA and, in certain cases, RNA-dependent RNA polymerase, as a part of the same area of interest.
Many of his studies involve connections with topics such as Molecular biology and RNA.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
